-
Main Points of Proposed Amendment (4th) to Chinese Patent Law
China's National People's Congress (NPC) has recently published an updated Draft of Proposed Amendment to Chinese Patent Law. This will be the Fourth (4th) amendment to the patent law and has been discussed for a number of years. The NPC is currently seeking public comments on the Draft.There are a number of important proposed changes to the law. We have paraphrased and hi
2020-07-14 -
First Ever Preliminary Injunction Issued by Chinese Court in Pharmaceutical Patent Case
The Beijing IP Court has issued a preliminary injunction against a patent infringer in a pharmaceutical case earlier this year. As far as we know, this is the first time that such an injunction is ordered by a Chinese court in a pharmaceutical patent case. As we briefly discuss below, the case will have huge implications for not only the pharmaceutical industry, but patent protecti
2020-04-27 -
Amendments to the Chinese Patent Examination Guideline Effective on November 1, 2019
On September 23, China National Intellectual Property Administration (“CNIPA”) formally announced the latest Amendment to the Patent Examination Guidelines (“Guidelines”), which will become effective on November 1, 2019. The stated purpose of the Amendment is to improve patent quality and efficiency of examination.Below is a summary of the keys amendments and ou
2019-11-06 -
China Sinda Assisted a Successful End of 2019 CEO Training Programme on Global Technology Innovation and IP
From October 15 to 17, “2019 CEO Training Programme on Global Technology Innovation and IP” that jointly organized by International Institutions of Intellectual Property Office of Singapore, IPR Daily and Singapore International Intellectual Property Exchange (SIIPEx) was successfully held in Singapore.Mr. Zhang Weilin, General Manager of China Sinda Singapore Off
2019-11-04 -
Record Amount of Damages Requested in Chinese Patent Case
A patent infringement dispute between two Chinese companies has seen a total amount of RMB 1 billion (about US$ 150 million) damages requested, a record for a Chinese patent infringement case.
2019-04-26
Our professionals include some of the most experienced and committed practitioners in their profession. Our attorney’s cross-domain specializations allow for seamless customized intellectual property solutions for clients’ needs.
Our people are the key to providing the full range of service capabilities our clients need by working together as integrated, multidisciplinary teams with each member drawing from a unique set of talents.
We invite you to review the wide range of their qualifications and capabilities.
Share
-
Beijing Office
-
Hong Kong Office
-
Singapore Office
-
Washington D.C. Office
-
Tokyo Office
-
Munich Office
Tel: +86-10-6657 6688
Fax: +86-10-6657 8088
E-mail: sinda@chinasinda.com
11/F, Tower B, Focus Place
19 Financial Street
Beijing 100033, P.R. China
Tel: +852-21109911
Fax: +852-21109973
E-mail: hk@chinasinda.com
Suite 3301 One Exchange Square
Central, Hong Kong
Tel: +65-62228501
Fax: +65-62228505
E-mail: weilin.zhang@chinasinda.com
133 Cecil Street
#12-01A Keck Seng Tower
Singapore 069535
Suite 205
17B Firstfield Road
Gaithersburg, MD 20878
USA
5-35-4 2F Sakurajosui, Setagaya-ku,
Tokyo, 156-0045 Japan
Tel: +49-89-57959117
Fax: +49-89-57959200
E-mail: munich@chinasinda.com
Regus Business Center
Landsberger Str. 155
80687 Munich
Germany
